Jayasimha Rayalu Daddam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jayasimha Rayalu Daddam has a total of 172 co-authors. Here are the top co-authors by number of shared publications:
- Maya Zachut
Department of Ruminant Science, Institute of Animal Sciences, Agricultural Research Organization, Volcani Institute
6 shared publications - Chih-Yang Huang
Department of Precision Chinese Herbal Medicine and Molecular Medicine Research, E-Da Hospital, I-Shou University, Kaohsiung 824, Taiwan
4 shared publications - Gitit Kra
Department of Ruminant Science, Institute of Animal Sciences, Volcani Institute, 68 HaMaccabim Road, Rishon LeZion 7505101, Israel
4 shared publications - Uzi Moallem
Department of Ruminant Science, Institute of Animal Sciences, The Volcani Institute, Rishon LeZion, Israel
4 shared publications Gitit Kra
Department of Ruminant Science, Volcani Center, Institute of Animal Sciences, Agricultural Research Organization, Rishon LeTsiyon, Israel
3 shared publicationsMounica Sura
Department of Food Technology, Jawaharlal Nehru Technological University Anantapur (JNTUA), Anantapuram, Andhra Pradesh, India
3 shared publications
Latest Publications
- Open Access
- 1 June 2026
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 109 (9) , 10015-10026
Skeletal muscle exhibits coordinated metabolic adaptations toward lipid utilization and enhanced redox capacity in high-feed-efficient dairy cows
Improving feed efficiency in dairy cattle requires a better understanding of tissue-specific mechanisms that support energy and nutrient utilization. Skeletal muscle represents a major proportion of body mass in dairy cows and plays a major role in post-absorptive metabolism. Our previous liver proteomics study highlighted that high-efficiency (HE) cows exhibit enhanced hepatic fatty acid oxidation, supporting lower feed intake without compromising productivity. This study aimed to identify muscle-based metabolic adaptations associated with feed efficiency. Skeletal muscle samples from 8 HE (low residual feed intake, RFI) and 8 low-efficiency (LE; high-RFI) mid-lactation (119 ± 33 DIM) Holstein cows, ranked at the top and bottom 10% of RFI, were analyzed using tandem mass tag proteomics and RT-qPCR to identify differences in skeletal muscle related to feed efficiency. HE cows had significantly greater muscle glycogen content and exhibited a coordinated metabolic shift favoring lipid utilization. RT-qPCR showed increased expression of β-oxidation (PPARA, ACADS, ACADVL, ACOX1) and triglyceride mobilization (ATGL) in HE cows. In contrast, proteomics revealed lower abundance of glycolytic and glycogenolytic enzymes (e.g., ALDOA, PFKM, PGAM2, PYGM, AGL) in HE muscle, indicating reduced glucose and glycogen catabolism. Proteins involved in the SLC2A4 (GLUT4) translocation pathway (ACTG1, YWHAH, YWHAZ) were more abundant in HE cows, suggesting an increased capacity for insulin-stimulated GLUT4 translocation, which may contribute to greater glycogen storage. Proteomics also showed enhanced redox regulation in HE cows, with greater abundance of GSR, CAT, GPX1, and PRDX2, and lower abundance of mitochondrial complexes I (NDUFB8) and III (UQCRC2), major sites of reactive oxygen species formation. These results indicate that skeletal muscle in HE cows adopts a metabolic phenotype characterized by increased reliance on lipid-derived fuels, glucose sparing, and improved oxidative homeostasis. Together with previously reported hepatic adaptations, these muscle-specific responses likely contribute to whole-animal feed efficiency in lactating dairy cows.
- 1 June 2026
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 109 (9) , 10015-10026
Open AccessSkeletal muscle exhibits coordinated metabolic adaptations toward lipid utilization and enhanced redox capacity in high-feed-efficient dairy cows
Improving feed efficiency in dairy cattle requires a better understanding of tissue-specific mechanisms that support energy and nutrient utilization. Skeletal muscle represents a major proportion of body mass in dairy cows and plays a major role in post-absorptive metabolism. Our previous liver proteomics study highlighted that high-efficiency (HE) cows exhibit enhanced hepatic fatty acid oxidation, supporting lower feed intake without compromising productivity. This study aimed to identify muscle-based metabolic adaptations associated with feed efficiency. Skeletal muscle samples from 8 HE (low residual feed intake, RFI) and 8 low-efficiency (LE; high-RFI) mid-lactation (119 ± 33 DIM) Holstein cows, ranked at the top and bottom 10% of RFI, were analyzed using tandem mass tag proteomics and RT-qPCR to identify differences in skeletal muscle related to feed efficiency. HE cows had significantly greater muscle glycogen content and exhibited a coordinated metabolic shift favoring lipid utilization. RT-qPCR showed increased expression of β-oxidation (PPARA, ACADS, ACADVL, ACOX1) and triglyceride mobilization (ATGL) in HE cows. In contrast, proteomics revealed lower abundance of glycolytic and glycogenolytic enzymes (e.g., ALDOA, PFKM, PGAM2, PYGM, AGL) in HE muscle, indicating reduced glucose and glycogen catabolism. Proteins involved in the SLC2A4 (GLUT4) translocation pathway (ACTG1, YWHAH, YWHAZ) were more abundant in HE cows, suggesting an increased capacity for insulin-stimulated GLUT4 translocation, which may contribute to greater glycogen storage. Proteomics also showed enhanced redox regulation in HE cows, with greater abundance of GSR, CAT, GPX1, and PRDX2, and lower abundance of mitochondrial complexes I (NDUFB8) and III (UQCRC2), major sites of reactive oxygen species formation. These results indicate that skeletal muscle in HE cows adopts a metabolic phenotype characterized by increased reliance on lipid-derived fuels, glucose sparing, and improved oxidative homeostasis. Together with previously reported hepatic adaptations, these muscle-specific responses likely contribute to whole-animal feed efficiency in lactating dairy cows.
- Open Access
- 14 April 2026
- Published by Horizon E-Publishing Group in Plant Science Today
- Vol. 13 (sp2)
Multifunctional roles of bacterial endophytes in plant growth, immunity and environmental adaptation
Endophytes are microorganisms such as bacteria, fungi, archaea and protists live inside the plant tissues without causing harm. Bacterial endophytes play a pivotal role in promoting plant growth and development. They are distributed across several phyla, including Pseudomonadota, Actinomycetota, Bacillota and Bacteroidot with genera such as Azoarcus, Burkholderia, Pseudomonas and Herbaspirillum enhancing plant biomass, root development and stress tolerance. Endophytes support plants by producing phytohormones such as indole-3-acetic acid (IAA), cytokinins, gibberellins, Abscisic acid and ethylene, solubilising phosphate, secreting siderophores and reducing stress-induced ethylene via the enzyme ACC deaminase. Colonisation involves sequential stages, beginning in the rhizosphere, followed by attachment to the rhizoplane and finally entry into internal tissues through natural openings or active mechanisms facilitated by pili, flagella and low-level cell wall–degrading enzymes. Endophytes modulate plant immunity by avoiding strong defence responses and producing antioxidant enzymes. They also enhance resistance to biotic and abiotic stresses, including pathogens, drought, salinity and heavy metals. Genes expressed in endophytes, such as those involved in nitrogen fixation, siderophore synthesis, quorum sensing and stress response, contribute to plant growth promotion. Harnessing bacterial endophytes offers sustainable alternatives to chemical fertilisers and pesticides, supporting environmental friendly agriculture and improved crop resilience under abiotic stress.
- 14 April 2026
- Published by Horizon E-Publishing Group in Plant Science Today
- Vol. 13 (sp2)
Open AccessMultifunctional roles of bacterial endophytes in plant growth, immunity and environmental adaptation
Endophytes are microorganisms such as bacteria, fungi, archaea and protists live inside the plant tissues without causing harm. Bacterial endophytes play a pivotal role in promoting plant growth and development. They are distributed across several phyla, including Pseudomonadota, Actinomycetota, Bacillota and Bacteroidot with genera such as Azoarcus, Burkholderia, Pseudomonas and Herbaspirillum enhancing plant biomass, root development and stress tolerance. Endophytes support plants by producing phytohormones such as indole-3-acetic acid (IAA), cytokinins, gibberellins, Abscisic acid and ethylene, solubilising phosphate, secreting siderophores and reducing stress-induced ethylene via the enzyme ACC deaminase. Colonisation involves sequential stages, beginning in the rhizosphere, followed by attachment to the rhizoplane and finally entry into internal tissues through natural openings or active mechanisms facilitated by pili, flagella and low-level cell wall–degrading enzymes. Endophytes modulate plant immunity by avoiding strong defence responses and producing antioxidant enzymes. They also enhance resistance to biotic and abiotic stresses, including pathogens, drought, salinity and heavy metals. Genes expressed in endophytes, such as those involved in nitrogen fixation, siderophore synthesis, quorum sensing and stress response, contribute to plant growth promotion. Harnessing bacterial endophytes offers sustainable alternatives to chemical fertilisers and pesticides, supporting environmental friendly agriculture and improved crop resilience under abiotic stress.
- Open Access
- 1 October 2025
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 108 (10) , 11672-11681
Branched-chain amino acid and ketoacid supplementation differentially modulate amino acid and ketoacid metabolisms and profiles in fresh cows
After calving, dairy cows experience a negative protein and AA balance, potentially impairing milk production and increasing susceptibility to metabolic disorders. The objectives of this study were to quantify circulating concentrations of proteinogenic AA and branched-chain keto acid (BCKA) and characterize mRNA expression of key enzymes regulating branched-chain AA (BCAA) catabolism. Thirty-six multiparous Holstein cows were enrolled in a randomized block design, receiving continuous abomasal infusion for 21 d after parturition. Treatments (12 cows each) were control (CON), cows abomasally infused with 0.9% saline; cows abomasally infused with BCAA (67 g Val, 50 g Leu, and 34 g Ile; BCA); and cows abomasally infused with BCKA (77 g keto Val, 57 g keto Leu, and 39 g keto Ile; BCK). All cows were randomly assigned to treatments after parturition and received the same diet throughout the experimental period. Blood was collected at 0, 3, 7, 14, and 21 d postpartum for quantification of 20 AA with liquid chromatography-tandem MS. Liver was also harvested on 7, 14, and 21 d postpartum for quantification of BCAA catabolism genes. Compared with CON, BCA cows had higher plasma BCAA, keto Leu, and keto Ile (but not keto Val), along with higher plasma EAA and total AA (TAA). Abomasal BCKA infusion increased plasma BCKA, Val, and Ile (but not Leu), and elevated plasma EAA without affecting TAA. The BCK cows had higher overall plasma Met and His. Additionally, at specific time points measured, BCA cows had higher concentrations of Lys and Arg compared with CON cows, while BCK cows had higher concentrations of Phe, Met, His, and glutamate compared with CON cows. Compared with CON, BCA cows had greater expression of all BCAA/BCKA catabolism genes for at least one time point measured, whereas BCK cows only exhibited greater expression of Methylcrotonyl-CoA Carboxylase Subunit 1 and Methylmalonyl-CoA Mutase on d 14 compared with CON. Overall, these results suggest that postruminal BCAA and BCKA infusion distinctly modulated AA profile and BCAA/BCKA catabolism in fresh cows, revealing divergent metabolic adaptations. These findings highlight the distinct roles of BCAA and BCKA in nutrient utilization and metabolic function during early lactation. Future work is required to evaluate specific changes in the interrelated metabolism of BCAA and BCKA to clarify their specific contributions to lactation performance and metabolic regulation.
- 1 October 2025
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 108 (10) , 11672-11681
Open AccessBranched-chain amino acid and ketoacid supplementation differentially modulate amino acid and ketoacid metabolisms and profiles in fresh cows
After calving, dairy cows experience a negative protein and AA balance, potentially impairing milk production and increasing susceptibility to metabolic disorders. The objectives of this study were to quantify circulating concentrations of proteinogenic AA and branched-chain keto acid (BCKA) and characterize mRNA expression of key enzymes regulating branched-chain AA (BCAA) catabolism. Thirty-six multiparous Holstein cows were enrolled in a randomized block design, receiving continuous abomasal infusion for 21 d after parturition. Treatments (12 cows each) were control (CON), cows abomasally infused with 0.9% saline; cows abomasally infused with BCAA (67 g Val, 50 g Leu, and 34 g Ile; BCA); and cows abomasally infused with BCKA (77 g keto Val, 57 g keto Leu, and 39 g keto Ile; BCK). All cows were randomly assigned to treatments after parturition and received the same diet throughout the experimental period. Blood was collected at 0, 3, 7, 14, and 21 d postpartum for quantification of 20 AA with liquid chromatography-tandem MS. Liver was also harvested on 7, 14, and 21 d postpartum for quantification of BCAA catabolism genes. Compared with CON, BCA cows had higher plasma BCAA, keto Leu, and keto Ile (but not keto Val), along with higher plasma EAA and total AA (TAA). Abomasal BCKA infusion increased plasma BCKA, Val, and Ile (but not Leu), and elevated plasma EAA without affecting TAA. The BCK cows had higher overall plasma Met and His. Additionally, at specific time points measured, BCA cows had higher concentrations of Lys and Arg compared with CON cows, while BCK cows had higher concentrations of Phe, Met, His, and glutamate compared with CON cows. Compared with CON, BCA cows had greater expression of all BCAA/BCKA catabolism genes for at least one time point measured, whereas BCK cows only exhibited greater expression of Methylcrotonyl-CoA Carboxylase Subunit 1 and Methylmalonyl-CoA Mutase on d 14 compared with CON. Overall, these results suggest that postruminal BCAA and BCKA infusion distinctly modulated AA profile and BCAA/BCKA catabolism in fresh cows, revealing divergent metabolic adaptations. These findings highlight the distinct roles of BCAA and BCKA in nutrient utilization and metabolic function during early lactation. Future work is required to evaluate specific changes in the interrelated metabolism of BCAA and BCKA to clarify their specific contributions to lactation performance and metabolic regulation.
- Open Access
- 1 January 2024
- Published by Japan Oil Chemists' Society in Journal of Oleo Science
- Vol. 73 (1) , 85-98
Anti-osteoarthritis, Bone Protective and Antiinflammatory Effect of Lusianthridin against Monosodium Iodoacetate Induced Osteoarthritis via Suppression of Inflammatory Pathway
Osteoarthritis (OA) is characterized by the gradual deterioration and worsening of the knee joint, leading to both pain and deformity. The current research exhibited the anti-osteoarthritis effect of lusianthridin against monosodium iodoacetate (MIA) induced OA in rats. RAW cells were used for the cell viability. The inflammatory cytokines and mediators were estimated in the cell lines after the lipopolysaccharide (LPS) treatment. For the in vivo study, the rats were received the intraperitoneal administration of MIA (3 mg/kg) for the induction of OA. The rats were received the oral administration of lusianthridin (5, 10 and 20 mg/kg) and the body and organ weight estimated. Antioxidant, cytokines, inflammatory and matrix metalloproteinases (MMP) level were also estimated. The mRNA expression of MMP were also estimated. The lusianthridin treatment remarkably suppressed the cell viability. LPS induced RAW cell suppressed the level of nitrate, tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), cyclooxygenase-2 (COX-2), prostaglandin (PGE2), MMP-2 and MMP-9 level. Lusianthridin remarkably altered the level of body weight and organ weight (liver, spleen, renal and heart weight). lusianthridin suppressed the oxidative stress via altered the level of antioxidant parameters. Lusianthridin significantly (p < 0.001) decreased the level of cartilage oligometrix matrix protein (COMP) and c-reactive protein (CRP); cytokines such as TNF-α, IL-1β, IL-6, IL-10; inflammatory parameters include 5- Lipoxygenase (5-LOX), COX-2, leukotriene B4 (LTB4), PGE2; transforming growth factor beta (TGF-β); MMP level like MMP-1, 3, 9, 13, respectively. Lusianthridin significantly suppressed the mRNA expression of MMP. Collectively, the result of the study showed that antiosteoarthritis effect of lusianthridin via suppression of inflammatory parameters.
- 1 January 2024
- Published by Japan Oil Chemists' Society in Journal of Oleo Science
- Vol. 73 (1) , 85-98
Open AccessAnti-osteoarthritis, Bone Protective and Antiinflammatory Effect of Lusianthridin against Monosodium Iodoacetate Induced Osteoarthritis via Suppression of Inflammatory Pathway
Osteoarthritis (OA) is characterized by the gradual deterioration and worsening of the knee joint, leading to both pain and deformity. The current research exhibited the anti-osteoarthritis effect of lusianthridin against monosodium iodoacetate (MIA) induced OA in rats. RAW cells were used for the cell viability. The inflammatory cytokines and mediators were estimated in the cell lines after the lipopolysaccharide (LPS) treatment. For the in vivo study, the rats were received the intraperitoneal administration of MIA (3 mg/kg) for the induction of OA. The rats were received the oral administration of lusianthridin (5, 10 and 20 mg/kg) and the body and organ weight estimated. Antioxidant, cytokines, inflammatory and matrix metalloproteinases (MMP) level were also estimated. The mRNA expression of MMP were also estimated. The lusianthridin treatment remarkably suppressed the cell viability. LPS induced RAW cell suppressed the level of nitrate, tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), cyclooxygenase-2 (COX-2), prostaglandin (PGE2), MMP-2 and MMP-9 level. Lusianthridin remarkably altered the level of body weight and organ weight (liver, spleen, renal and heart weight). lusianthridin suppressed the oxidative stress via altered the level of antioxidant parameters. Lusianthridin significantly (p < 0.001) decreased the level of cartilage oligometrix matrix protein (COMP) and c-reactive protein (CRP); cytokines such as TNF-α, IL-1β, IL-6, IL-10; inflammatory parameters include 5- Lipoxygenase (5-LOX), COX-2, leukotriene B4 (LTB4), PGE2; transforming growth factor beta (TGF-β); MMP level like MMP-1, 3, 9, 13, respectively. Lusianthridin significantly suppressed the mRNA expression of MMP. Collectively, the result of the study showed that antiosteoarthritis effect of lusianthridin via suppression of inflammatory parameters.
- 10 May 2023
- Published by Wiley in Environmental Toxicology
- Vol. 38 (8) , 1989-2001
The HDAC2 / YY1 / c‐Myc signaling axis regulates lung cancer cell migration and proliferation
Lung cancer is among the most aggressive types of malignant tumors that contributes to cancer‐associated deaths worldwide with a high occurrence and fatality rate. Histone deacetylase 2 (HDAC2), prevent the aberrant transcription of a number of genes that are primarily responsible for controlling the cell cycle, cell proliferation, and signaling pathways in numerous cancers. Previous studies reported the role of HDACs and YY1 in the growth and development of several cancers. Although, it is noteworthy that remarkable efforts have been taken for the treatment of lung cancer using molecularly targeted therapies and chemotherapeutic agents, but the outcome is still poor for this critically persistent cancer. Therefore, the aim of the present study is to identify an efficacious, novel therapeutic biomarkers for the successful diagnosis of lung cancer at the early stage of the disease and the molecular insights involved. In the present study, qPCR and western bot data revealed that the expression level of HDAC2 and YY1 were upregulated in the cell lines and tumor samples of lung cancer patients. Moreover, MTT, qPCR, western blot, cell cycle analysis, and migration assays showed that inhibition of HDAC2 reduced YY1 expression, similarly, depletion of YY1 using knockdown approach inhibited the proliferation, migration, invasion, and blockage of the cell cycle by suppressing c‐Myc in lung cancer cell lines. In conclusion, the current study findings support the notion that HDAC2's anticancer role was attributed through YY1 regulation by targeting c‐Myc and could act as potential novel candidate biomarker for the lung cancer diagnosis.
- 10 May 2023
- Published by Wiley in Environmental Toxicology
- Vol. 38 (8) , 1989-2001
The HDAC2 / YY1 / c‐Myc signaling axis regulates lung cancer cell migration and proliferation
Lung cancer is among the most aggressive types of malignant tumors that contributes to cancer‐associated deaths worldwide with a high occurrence and fatality rate. Histone deacetylase 2 (HDAC2), prevent the aberrant transcription of a number of genes that are primarily responsible for controlling the cell cycle, cell proliferation, and signaling pathways in numerous cancers. Previous studies reported the role of HDACs and YY1 in the growth and development of several cancers. Although, it is noteworthy that remarkable efforts have been taken for the treatment of lung cancer using molecularly targeted therapies and chemotherapeutic agents, but the outcome is still poor for this critically persistent cancer. Therefore, the aim of the present study is to identify an efficacious, novel therapeutic biomarkers for the successful diagnosis of lung cancer at the early stage of the disease and the molecular insights involved. In the present study, qPCR and western bot data revealed that the expression level of HDAC2 and YY1 were upregulated in the cell lines and tumor samples of lung cancer patients. Moreover, MTT, qPCR, western blot, cell cycle analysis, and migration assays showed that inhibition of HDAC2 reduced YY1 expression, similarly, depletion of YY1 using knockdown approach inhibited the proliferation, migration, invasion, and blockage of the cell cycle by suppressing c‐Myc in lung cancer cell lines. In conclusion, the current study findings support the notion that HDAC2's anticancer role was attributed through YY1 regulation by targeting c‐Myc and could act as potential novel candidate biomarker for the lung cancer diagnosis.
- 20 February 2023
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 14 (1) , 100700
“Retraction Notice to ‘Evaluation of therapeutic and toxic levels of Conium maculatum L. extract in gestation and foetal development of adult albino rats” [Journal of Ayurveda and Integrtaive Medicine 13 (2022)100621]
- 20 February 2023
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 14 (1) , 100700
“Retraction Notice to ‘Evaluation of therapeutic and toxic levels of Conium maculatum L. extract in gestation and foetal development of adult albino rats” [Journal of Ayurveda and Integrtaive Medicine 13 (2022)100621]
- Open Access
- 20 February 2023
- Published by MDPI AG in Metabolites
- Vol. 13 (2) , 312
Glucose-6-Phosphate Dehydrogenase Activity in Milk May Serve as a Non-Invasive Metabolic Biomarker of Energy Balance in Postpartum Dairy Cows
Negative energy balance (EB) postpartum is associated with adverse outcomes in dairy cows; therefore, non-invasive biomarkers to measure EB are of particular interest. We determined whether specific metabolites, oxidative stress indicators, enzyme activity, and fatty acid (FA) profiles in milk can serve as indicators of negative EB. Forty-two multiparous Holstein dairy cows were divided at calving into 2 groups: one was milked 3 times daily and the other, twice a day for the first 30 d in milk (DIM). Cows were classified retrospectively as being in either negative EB (NEB, n = 19; the mean EB during the first 21 DIM were less than the overall median of −2.8 Mcal/d), or in positive EB (PEB, n = 21; the mean EB was ≥−2.8 Mcal/d). The daily milk yield, feed intake, and body weight were recorded individually. Blood samples were analyzed for metabolites and stress biomarkers. Milk samples were taken twice weekly from 5 to 45 DIM to analyze the milk solids, the FA profile, glucose, glucose-6-P (G6P), G6P-dehydrogenase (G6PDH) activity, malic and lactic acids, malondialdehyde (MDA), and oxygen radical antioxidant capacity (ORAC). The NEB cows produced 10.5% more milk, and consumed 7.6% less dry matter than the PEB cows. The plasma glucose concentration was greater and β-hydroxybutyrate was lower in the PEB vs. the NEB cows. The average concentrations of milk glucose, G6P, malic and lactic acids, and MDA did not differ between groups; however, the G6PDH activity was higher and ORAC tended to be higher in the milk of NEB vs. the PEB cows. The correlation between milk G6PDH activity and EB was significant (r = −0.39). The percentages of oleic acid and total unsaturated FA in milk were higher for the NEB vs. the PEB cows. These findings indicate that G6PDH activity in milk is associated with NEB and that it can serve as a non-invasive candidate biomarker of NEB in postpartum cows, that should be validated in future studies.
- 20 February 2023
- Published by MDPI AG in Metabolites
- Vol. 13 (2) , 312
Open AccessGlucose-6-Phosphate Dehydrogenase Activity in Milk May Serve as a Non-Invasive Metabolic Biomarker of Energy Balance in Postpartum Dairy Cows
Negative energy balance (EB) postpartum is associated with adverse outcomes in dairy cows; therefore, non-invasive biomarkers to measure EB are of particular interest. We determined whether specific metabolites, oxidative stress indicators, enzyme activity, and fatty acid (FA) profiles in milk can serve as indicators of negative EB. Forty-two multiparous Holstein dairy cows were divided at calving into 2 groups: one was milked 3 times daily and the other, twice a day for the first 30 d in milk (DIM). Cows were classified retrospectively as being in either negative EB (NEB, n = 19; the mean EB during the first 21 DIM were less than the overall median of −2.8 Mcal/d), or in positive EB (PEB, n = 21; the mean EB was ≥−2.8 Mcal/d). The daily milk yield, feed intake, and body weight were recorded individually. Blood samples were analyzed for metabolites and stress biomarkers. Milk samples were taken twice weekly from 5 to 45 DIM to analyze the milk solids, the FA profile, glucose, glucose-6-P (G6P), G6P-dehydrogenase (G6PDH) activity, malic and lactic acids, malondialdehyde (MDA), and oxygen radical antioxidant capacity (ORAC). The NEB cows produced 10.5% more milk, and consumed 7.6% less dry matter than the PEB cows. The plasma glucose concentration was greater and β-hydroxybutyrate was lower in the PEB vs. the NEB cows. The average concentrations of milk glucose, G6P, malic and lactic acids, and MDA did not differ between groups; however, the G6PDH activity was higher and ORAC tended to be higher in the milk of NEB vs. the PEB cows. The correlation between milk G6PDH activity and EB was significant (r = −0.39). The percentages of oleic acid and total unsaturated FA in milk were higher for the NEB vs. the PEB cows. These findings indicate that G6PDH activity in milk is associated with NEB and that it can serve as a non-invasive candidate biomarker of NEB in postpartum cows, that should be validated in future studies.
- Open Access
Illuminating the Molecular Intricacies of Exosomes and ncRNAs in Cardiovascular Diseases: Prospective Therapeutic and Biomarker Potential
Cardiovascular diseases (CVDs) are one of the leading causes of death worldwide. Accumulating evidences have highlighted the importance of exosomes and non-coding RNAs (ncRNAs) in cardiac physiology and pathology. It is in general consensus that exosomes and ncRNAs play a crucial role in the maintenance of normal cellular function; and interestingly it is envisaged that their potential as prospective therapeutic candidates and biomarkers are increasing rapidly. Considering all these aspects, this review provides a comprehensive overview of the recent understanding of exosomes and ncRNAs in CVDs. We provide a great deal of discussion regarding their role in the cardiovascular system, together with providing a glimpse of ideas regarding strategies exploited to harness their potential as a therapeutic intervention and prospective biomarker against CVDs. Thus, it could be envisaged that a thorough understanding of the intricacies related to exosomes and ncRNA would seemingly allow their full exploration and may lead clinical settings to become a reality in near future.
Open AccessIlluminating the Molecular Intricacies of Exosomes and ncRNAs in Cardiovascular Diseases: Prospective Therapeutic and Biomarker Potential
Cardiovascular diseases (CVDs) are one of the leading causes of death worldwide. Accumulating evidences have highlighted the importance of exosomes and non-coding RNAs (ncRNAs) in cardiac physiology and pathology. It is in general consensus that exosomes and ncRNAs play a crucial role in the maintenance of normal cellular function; and interestingly it is envisaged that their potential as prospective therapeutic candidates and biomarkers are increasing rapidly. Considering all these aspects, this review provides a comprehensive overview of the recent understanding of exosomes and ncRNAs in CVDs. We provide a great deal of discussion regarding their role in the cardiovascular system, together with providing a glimpse of ideas regarding strategies exploited to harness their potential as a therapeutic intervention and prospective biomarker against CVDs. Thus, it could be envisaged that a thorough understanding of the intricacies related to exosomes and ncRNA would seemingly allow their full exploration and may lead clinical settings to become a reality in near future.
- Open Access
- 9 August 2022
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 13 (3) , 100621
RETRACTED: Evaluation of therapeutic and toxic levels of Conium maculatum L. extract in gestation and foetal development of adult albino rats
- 9 August 2022
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 13 (3) , 100621
Open AccessRETRACTED: Evaluation of therapeutic and toxic levels of Conium maculatum L. extract in gestation and foetal development of adult albino rats